Episode 29 - Adrian Rawcliffe, CEO of Adaptimmune

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m pleased to introduce Adrian Rawcliffe, CEO of Adaptimmune Therapeutics. With over 20 years of experience in the pharmaceutical and biotech industries, Adrian has led pivotal roles at GSK and now spearheads the development of breakthrough T-cell therapies at Adaptimmune, tackling some of the toughest challenges in cancer and beyond. We’re excited to dive into Adrian’s journey, the advancements at Adaptimmune, and what the future holds for T-cell therapies. Welcome to the show, Adrian! Enjoy and stay tuned.

Episode metadata supplied by the publisher feed · Published Dec 18, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 29 - Adrian Rawcliffe, CEO of Adaptimmune

0:00 44:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 44 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on December 18, 2024.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!